Shardul Amarchand Mangaldas & Co. advises Zen Technologies Limited (“Issuer”) on its Qualified Institutions Placement aggregating to INR 1,000 crores. The deal was closed on August 23, 2024.   Zen Technologies is one of the India’s few companies that operates in the defence training and simulation and anti-drone systems segments. Their proprietary training platform integrates… Read More +

Shardul Amarchand Mangaldas & Co. advised Poly Medicure Limited (“Company”) on its qualified institutions placement of equity shares of face value of INR 5 each (“Equity Shares”) aggregating to approximately INR 1,000 crore (“Issue”). The deal was closed on August 22, 2024.   Poly Medicure Limited is among the top five companies in the medical… Read More +

Shardul Amarchand Mangaldas & Co. advised Interarch Building Products Limited, a leading turnkey pre-engineered steel building solution provider in India with integrated facilities for design and engineering, manufacturing, on-site project management capabilities for the installation and erection of pre-engineered steel buildings, on its initial public offering of equity shares (IPO) of approximately US$ 72 million.… Read More +

Shardul Amarchand Mangaldas & Co. is pleased to announce the appointment of Mahesh Wasadikar as a Partner in the General Corporate Practice. He will be based out of the Firm’s Mumbai office and will be advising clients on various aspects of General corporate transactions.   Mahesh brings over a decade long extensive experience, specialising in… Read More +

Shardul Amarchand Mangaldas & Co. successfully represented Apollo Hospitals Enterprise Limited (AHEL), Apollo Healthco Limited (AHL) and Keimed Private Limited (Keimed) before the Competition Commission of India (CCI) in Advent International L.P.’s investment (through Rasmeli Limited (Rasmeli)) in AHL, AHL’s investment in Keimed and Keimed’s merger into AHL.   The transaction will result in the… Read More +